These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16182183)

  • 1. Erythema nodosum secondary to granulocyte colony-stimulating factor in a patient with Hodgkin lymphoma during CD34+ cell mobilization for autologous peripheral blood stem cell transplantation: a dose-mediated effect.
    George S; George B; Gorak E
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):816-7. PubMed ID: 16182183
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure.
    Lefrère F; Lévy V; Makke J; Audat F; Cavazzana-Calvo M; Micléa JM
    Haematologica; 2004 Dec; 89(12):1532-4. PubMed ID: 15590409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony-stimulating factor.
    Lefrère F; Brignier AC; Elie C; Ribeil JA; Bernimoulin M; Aoun C; Dal Cortivo L; Delarue R; Hermine O; Cavazzana-Calvo M
    Adv Ther; 2011 Apr; 28(4):304-10. PubMed ID: 21400232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.
    Akhtar S; Tbakhi A; Humaidan H; El Weshi A; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2006 Feb; 37(3):277-82. PubMed ID: 16400345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.
    Balaguer H; Galmes A; Ventayol G; Bargay J; Besalduch J
    Transfusion; 2004 Aug; 44(8):1260-1. PubMed ID: 15265137
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
    Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
    Lefrère F; Zohar S; Bresson JL; Chevret S; Mogenet A; Audat F; Durand-Zaleski I; Ghez D; Dal Cortivo L; Piesvaux P; Cavazzana-Calvo M; Varet B
    Haematologica; 2006 Apr; 91(4):550-3. PubMed ID: 16585020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is G-CSF-mobilized peripheral stem cell harvest harmful?
    Donadieu J
    Pediatr Blood Cancer; 2007 May; 48(5):594-5; author reply 595-7. PubMed ID: 16767714
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease.
    Sinha S; Poh KK; Sodano D; Flanagan J; Ouilette C; Kearney M; Heyd L; Wollins J; Losordo D; Weinstein R
    J Clin Apher; 2006 Jul; 21(2):116-20. PubMed ID: 16342193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy during peripheral blood stem cell mobilization.
    Naina HV; Gertz MA; Elliott MA
    J Clin Apher; 2009; 24(6):259-61. PubMed ID: 19877288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens.
    Nosari A; Cairoli R; Ciapanna D; Gargantini L; Intropido L; Baraté C; Scarpati B; Santoleri L; Nador G; Pezzetti L; Morra E
    Bone Marrow Transplant; 2006 Sep; 38(6):413-6. PubMed ID: 16878144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
    Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
    Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.